Equities

Schrodinger Inc

Schrodinger Inc

Actions
TechnologyTechnology
  • Price (USD)20.37
  • Today's Change1.20 / 6.26%
  • Shares traded805.17k
  • 1 Year change-30.55%
  • Beta1.5225
Data delayed at least 15 minutes, as of Nov 21 2024 21:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.

  • Revenue in USD (TTM)193.35m
  • Net income in USD-177.58m
  • Incorporated1995
  • Employees867.00
  • Location
    Schrodinger Inc1540 BROADWAY, 24TH FLOORNEW YORK 10036United StatesUSA
  • Phone+1 (503) 299-1150
  • Fax+1 (302) 655-5049
  • Websitehttps://www.schrodinger.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
QuinStreet Inc768.81m-22.13m1.26bn899.00--5.74431.771.64-0.4025-0.402513.913.922.13--6.36855,183.60-6.13-3.34-9.20-4.548.729.54-2.88-2.24---44.330.00--5.666.1554.50--31.17--
Amplitude Inc292.54m-80.27m1.29bn675.00--4.53--4.43-0.6596-0.65962.402.310.6597--9.41433,398.50-18.10---27.12--74.23---27.44------0.00--16.05--3.23------
Enfusion Inc195.16m3.34m1.30bn1.10k385.7918.5677.926.650.02620.02621.640.54431.65--6.84177,095.303.92--6.28--67.15--2.38------0.00--16.09--173.55------
Blend Labs Inc156.72m-85.79m1.33bn881.00------8.51-0.3418-0.34180.62220.34350.6213--8.03177,883.10-28.98---44.71--54.58---46.64-----4.460.00---33.31--75.89------
LegalZoom.com Inc678.84m24.49m1.34bn1.19k58.5522.3523.491.980.13250.13253.630.34731.75--52.35570,452.106.32--20.76--64.26--3.61------0.00--6.57--128.63------
Sabre Corp3.00bn-301.35m1.42bn6.23k------0.4717-0.7891-0.78697.85-4.040.6363--6.83481,690.30-6.38-11.02-8.24-13.0258.8048.29-10.02-24.14--0.61751.44--14.61-5.54-18.86---20.99--
Schrodinger Inc193.35m-177.58m1.48bn867.00--3.30--7.67-2.45-2.452.676.170.2642--5.03223,008.10-24.27-9.33-28.47-10.8764.9157.58-91.84-35.93----0.00--19.7326.59127.29--20.58--
Webtoon Entertainment Inc-100.00bn-100.00bn1.51bn1.85k--0.9385----------12.58----------------------------0.00--18.84--10.49------
Zuora Inc445.68m-47.27m1.52bn1.62k--7.81--3.41-0.3252-0.32523.061.270.5822--4.95275,453.00-6.17-20.82-9.61-36.7767.6559.84-10.61-29.74---13.250.6554--8.9812.9365.55---5.73--
Matterport Inc165.43m-260.06m1.53bn438.00--3.79--9.22-0.8245-0.82450.52561.260.28978.6910.30377,684.90-45.54---54.58--47.69---157.21--2.72--0.00--15.88---78.80------
Sapiens International Corporation N.V.538.93m71.29m1.54bn5.00k21.683.2616.592.851.271.279.618.460.8083--5.17107,786.6010.727.2613.669.2843.4041.3713.2610.36----0.077547.288.3912.1818.7335.275.5520.59
Certara Inc372.80m-31.08m1.57bn1.34k--1.4946.854.22-0.1944-0.19442.336.550.2429--4.34278,622.60-2.02-1.68-2.19-1.7959.6860.39-8.34-7.86---0.27480.2194--5.5716.70-475.79--5.93--
FinVolution Group (ADR)1.77bn307.73m1.63bn3.65k5.450.8143--0.92171.151.156.647.720.5702--5.76486,091.109.9412.7910.9615.0782.2381.7317.4224.64----0.000412.0712.6923.593.29-1.0643.41--
Goodrx Holdings Inc790.39m-16.22m1.64bn694.00--2.3521.012.07-0.0391-0.03912.021.830.5161--6.271,138,883.00-1.06-4.89-1.15-5.1793.5293.05-2.05-9.20--1.580.4137---2.1224.6372.99--74.38--
Opera Ltd (ADR)450.57m159.53m1.71bn592.009.741.879.813.791.981.985.7610.310.4709--6.67761,104.8016.673.9518.274.2674.8587.0835.4115.24----0.009752.7319.9119.76919.6334.98-4.09--
Data as of Nov 21 2024. Currency figures normalised to Schrodinger Inc's reporting currency: US Dollar USD

Institutional shareholders

59.36%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20247.91m12.44%
Bill & Melinda Gates Foundation Trust (Investment Management)as of 30 Sep 20246.98m10.97%
The Vanguard Group, Inc.as of 30 Sep 20246.54m10.28%
Rubric Capital Management LPas of 30 Sep 20243.69m5.79%
ARK Investment Management LLCas of 30 Sep 20242.34m3.67%
Nikko Asset Management Co., Ltd.as of 30 Sep 20242.19m3.44%
SSgA Funds Management, Inc.as of 30 Sep 20242.16m3.39%
Credit Suisse Asset Management (Schweiz) AGas of 30 Sep 20242.04m3.21%
Baillie Gifford & Co.as of 30 Sep 20241.98m3.11%
Massachusetts Financial Services Co.as of 30 Sep 20241.95m3.06%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.